Medical news of portal is the most update information on pharmaceutical and medical equipment market



The periodical about the pharmaceutical and medical equipment markets


(Russian pharmacies) - specialized periodical edition for pgarmacy professionals


Medical Council - Scientific Journal for Physicians



International expansion and bringing affordable biosimilars to patients are two of the stated aims of privately-held Russian biotech company Biocad, and the company has taken a step forward on both fronts with news on one of its products.
Up to 10 domestic and leading global drugmakers operating in the Russian market are considering reducing prices for their drugs, and in particular those intended for the treatment of the most serious diseases, including HIV/AIDS, hepatitis C, tuberculosis and some others.
CPhI Russia @IPhEB returns to the Russian capital – taking place at the JSC VDNH (VVC), Moscow from March 28 to 30 – as the Government’s Pharma 2020 plan continues to stimulate demand for international pharmaceutical ingredients, manufacturing and packaging equipment.
The Russian government is ready to allow the production of anti-HIV drugs bypassing patents of their right-holders.
The Russian Ministry of Health (MoH) has awarded domestic biotech firm Biocad marketing authorization for its interferon beta-1a biosimilar, a knockoff of Merck KGaA's (MRK: DE) Biogen’s Rebif that is a key component in treatment of relapsing-remitting multiple sclerosis (RRMS) and included in all international recommendations and protocols.
News 11 - 15 из 893
Начало | Пред. | 1 2 3 4 5 | След. | КонецВсе

Remedium group


publishing house


programmer of electronic software products


advertisement agency


rent-a-rep company